Navigation Links
Post-marketing studies finding adverse events in drugs used in children
Date:9/1/2008

DURHAM, NC -- The Food and Drug Administration Modernization Act (FDAMA, 1997), designed to stimulate more drug safety studies in children, has resulted in more than 130 label changes since its inception nearly six years ago, according to researchers at Duke Children's Hospital.

Their analysis appears in the September issue of Pediatrics.

Under this and subsequent renewal of this legislation, pharmaceutical companies were given a six-month extension of their exclusive marketing rights on a drug if they performed clinical trials requested by the FDA to determine the drugs' safety, dosing, and efficacy in children.

According to P. Brian Smith, MD, an assistant professor in Duke's department of pediatrics, many safety concerns cannot be detected until after the introduction of a product to a larger and more diverse population. The Best Pharmaceuticals for Children Act (2002) required the FDA to review and report to a public expert panel the adverse events occurring after granting pediatric exclusivity. That effort was needed because pediatric clinical trials are notoriously small, making it more likely that some safety concerns would not be detected until after the drug is used in a larger pediatric population.

Using MedWatch, the FDA's computerized information database for collecting reports of adverse events, the FDA's Pediatric Advisory Committee reviewed 67 drugs granted the extension. "This is a voluntary, cost-effective reporting system that can identify adverse events that may never have been seen in a clinical trial," Smith said.

"Just because a drug goes through testing and clinical trials does not mean its entire safety profile is known," says Danny Benjamin, MD, a co-author of the study and pediatrician at Duke Children's Hospital. "Before this incentive, there was no systematic, focused pediatric review of the data provided to the FDA's adverse event reporting system. Now, field experts in pediatr
'/>"/>

Contact: Debbe Geiger
Debbe.Geiger@duke.edu
919-660-9461
Duke University Medical Center
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Gene Studies of Male-Female Differences Often Flawed
2. Two studies published in the Lancet
3. Study of Studies Finds No Risk to Children From Phthalates in Toys
4. Just Completed Studies Reveal Impact of New Medicare Reimbursement Regulations
5. Studies Prove Exercise Can Heal the Body Mind and Soul
6. Studies Shed New Light on Breast Cancer, Treatment
7. Multi-Year Compendium of Pharmaceutical Case Studies Available from Best Practices, LLC
8. Genomic Health Announces Multiple Studies on Oncotype DX(TM) Presented at 2007 American Society of Clinical Oncology (ASCO) Breast Cancer Symposium
9. Best Practice Database: Complimentary Excerpt of Three Sales Force Excellence Studies
10. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
11. NIH awards Einstein multimillion dollar grant to extend studies of exceptional longevity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... (PRWEB) , ... July 31, 2015 , ... Ticket Down is a reputable source of ... the MGM Grand Garden Arena. Fans of every genre of music will have an ... 18th, the first day of the festival, the following artists will perform: Sam Smith, ...
(Date:7/31/2015)... CA (PRWEB) , ... August 01, 2015 , ... Super Bowl 50 will ... National Football League’s biggest day each year is the Super Bowl. In the two weeks ... takes place from the host venue. The 2016 Super Bowl game will mark the 50th ...
(Date:7/31/2015)... ... July 31, 2015 , ... Recently touted by Becker’s Healthcare ... health analytics , Jvion continues to disrupt the predictive analytic and big data ... patient and population level illness to drive prevention and better health outcomes. Most ...
(Date:7/31/2015)... ... July 31, 2015 , ... Sculpted Contours Luxury Medical Aesthetics announces the arrival ... Zeltiq Aesthetics released this new applicator in the United States as an upgrade to ... thighs. The original applicator required a 2 hour treatment time. The new ...
(Date:7/31/2015)... ... July 31, 2015 , ... Facebook, Twitter, Linkedin and blogs ... social media profiles to better connect with the public. The agency website at ... share insights and opinions. The Rally Insurance Group, Inc.’s pledge to provide effortless ...
Breaking Medicine News(10 mins):Health News:Cheap 2015 iHeartRadio Music Festival Tickets in Las Vegas at MGM Grand Garden Arena: Ticket Down Slashes Ticket Prices on the iHeart Radio Music Festival in Vegas 2Health News:Cheap 2015 iHeartRadio Music Festival Tickets in Las Vegas at MGM Grand Garden Arena: Ticket Down Slashes Ticket Prices on the iHeart Radio Music Festival in Vegas 3Health News:Cheap 2016 Super Bowl Tickets at Levi's Stadium: Ticket Down Slashes Ticket Prices on Super Bowl 50 Tickets in Santa Clara, CA at Levi's Stadium 2Health News:Jvion Showcased as Leader in the Predictive Analytic Market 2Health News:Cooler Coolsculpting in Atlanta: Treatments Now Twice As Fast 2Health News:Cooler Coolsculpting in Atlanta: Treatments Now Twice As Fast 3Health News:Rally Insurance Group, Inc. Connects to Customers Through Re-branded Social Media Profiles 2
... , SALT LAKE CITY, Aug. 4 ... the Office of National Drug Control Policy (ONDCP) to become a key ... In contrast to other approaches combating meth addiction, the End Meth Now ... the drug. , , "We,ve had the ...
... HOUSTON, Aug. 4 Cyberonics, Inc. (Nasdaq: CYBX ) today ... July 24, 2009 of its fiscal year ending April 30, 2010 on Wednesday, ... conference call to discuss those results on Thursday, August 20, 2009 at 9:00 ... Quarter Results Conference Call Instructions , To listen to the conference ...
... , Draconian Cuts to Medicare Compounded by Further ... from Weakened State Budgets , , WASHINGTON, ... a national coalition of community long term care businesses and organizations ... - today cautioned that the Centers for Medicare & Medicaid Services, ...
... smoking raise Alzheimer,s risk , TUESDAY, Aug. 4 ... your heart in the middle years of life -- ... are bad for your brain in later years, new ... associated with an increased risk of Alzheimer,s disease and ...
... Effort aims to create an international ... pursue a co-operative and collaborative approach to combating the problem ... WASHINGTON, Aug. 4 The National Health Care Anti-Fraud ... of Understanding with two like-minded organizations--the Canadian Health Care Anti-fraud ...
... ATLANTA, Aug. 4 CryoLife, Inc., (NYSE: ... cardiovascular tissue processing company, today announced it has received ... The CE mark allows immediate, unrestricted commercial distribution of ... adjunct in the sealing of abdominal parenchymal tissues (liver ...
Cached Medicine News:Health News:Office of National Drug Control Policy Taps RIESTER creative for Use in National Anti-Meth Campaign 2Health News:Cyberonics Announces Conference Call to Discuss Fiscal Year 2010 First Quarter Financial Results 2Health News:National Long Term Care Community Business Coalition Cautions Severe $16 Billion Medicare Cuts to Nursing Home Care Will Not Only Jeopardize Quality Care to Seniors but Deeply Impact Businesses that Support Sector, Contribute to Local Economies 2Health News:Midlife Heart Risk Factors Linked to Later Dementia 2Health News:Midlife Heart Risk Factors Linked to Later Dementia 3Health News:The National Health Care Anti-Fraud Association Signs Memorandum of Understanding With Canadian and European Anti-Fraud Organizations 2Health News:The National Health Care Anti-Fraud Association Signs Memorandum of Understanding With Canadian and European Anti-Fraud Organizations 3Health News:CryoLife Receives CE Mark Approval for BioFoam(R) Hemostatic Technology 2Health News:CryoLife Receives CE Mark Approval for BioFoam(R) Hemostatic Technology 3Health News:CryoLife Receives CE Mark Approval for BioFoam(R) Hemostatic Technology 4
(Date:7/30/2015)... 30, 2015 PTC Therapeutics, Inc. (NASDAQ: ... financial results for the second quarter ending June 30, ... fronts across the organization.  We are excited to be ... clinical trial ever conducted with topline results expected in ... Executive Officer, PTC Therapeutics, Inc. "Translarna is now commercially ...
(Date:7/30/2015)... , July 30, 2015  Cleveland Clinic President ... keynote address last month that industry is compelled to ... to gain the efficiencies—and develop the transformational innovations -- ... Barsoum,s comments were preceded by Doug Kohrs , ... OMTEC moderator, who stressed that industry must add "episode ...
(Date:7/30/2015)... New York , July 30, 2015 ... of its latest report titled, "Continuous Glucose Monitoring Systems ... 2020". According to the report, the global continuous glucose ... in 2014 and is expected to reach US$ 788.4 ... the forecast period, 2015 to 2020. Global ...
Breaking Medicine Technology:PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 2PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 3PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 4PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 5PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 6PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 7PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 8PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 9PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 10Orthopaedic Surgery Reimbursement Shifts to Episode of Care 2Global Continuous Glucose Monitoring (CGM) Systems Market: Transmitters and Monitors Most Dominant Segment, Says Future Market Insights 2Global Continuous Glucose Monitoring (CGM) Systems Market: Transmitters and Monitors Most Dominant Segment, Says Future Market Insights 3Global Continuous Glucose Monitoring (CGM) Systems Market: Transmitters and Monitors Most Dominant Segment, Says Future Market Insights 4
... May 16, 2011 Telik, Inc. (Nasdaq: TELK ... March 31, 2011.  The net loss for the quarter ended ... a net loss of $5.3 million, or $0.10 per share, for ... development expenses (R&D) in the first quarter of 2011 were ...
... Red Hill Studios, in partnership with the UCSF School ... physical therapy games that have been specifically designed to ... neurodegenerative disease. Sue Lifschiz, a woman with Parkinson,s, will ... difficulty levels to meet the needs of a variety ...
Cached Medicine Technology:Telik Announces First Quarter 2011 Financial Results 2Telik Announces First Quarter 2011 Financial Results 3Red Hill Studios/UCSF Partnership to Showcase 'Gaming Therapy' for People With Parkinson's Disease at Games for Health Conference 2Red Hill Studios/UCSF Partnership to Showcase 'Gaming Therapy' for People With Parkinson's Disease at Games for Health Conference 3
Facilitates intubation of tracheal tubes....
Disposable Aluminum Satin Finish E/T Stylette, Pediatric 11 1/2, 25/box....
Fiber Optic Stylette with Adjustable Stop 18., ,Fiber optic handles require two AA batteries not included....
Aluminum Stylette 16 with Adjustable Stop....
Medicine Products: